Table 3

Discussions at patient-provider visits
All participants All non-routine recommendations Disease-specific non-routine recommendations
Breast Cancer∞
Risk of breast cancer 48 (22.8%) 29 (23.2%) 18 (32.7%)
Mammography 125 (59.2%) 68 (54.4%) 33 (60.0%)
Breast MRI 10 (4.7%) 8 (6.4%) 5 (9.1%)
Tamoxifen 6 (2.8%) 5 (4%) 4 (7.3%)
Ovarian Cancer∞ 19 (9.0%) 13 (10.4%) 6 (50%)
Colon cancer*
Risk of colon cancer 113 (30.5%) 50 (29.2%) 39 (34.8%)
Screening for colon cancer 260 (70.3%) 118 (69.0%) 83 (74.1%)
Thrombosis* 35 (9.5%) 18 (10.5%) 10 (41.7%)
Seeing a specialist* 82 (22.2%) 62 (36.3%) n/a
Lifestyle choices* 192 (51.9%) 83 (48.5%) n/a

∞Total N = 211 for all participants; 125 for all non-routine recommendations; 55 for breast cancer-specific non-routine recommendations; 12 for ovarian cancer-specific non-routine recommendations.

*Total N = 370 for all participants; 171 for all non-routine recommendations; 112 for colon cancer-specific non-routine recommendations; 24 for thrombosis-specific non-routine recommendations.

Wu et al.

Wu et al. BMC Family Practice 2013 14:111   doi:10.1186/1471-2296-14-111

Open Data